Physician profile
Randal E White
NPI 1184629297
$3,878.88
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $1,101 · 2021: $1,198 · 2022: $18.68.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,076.09 | 2019-2022 | |
| Pfizer INC. | $942.72 | 2019-2021 | |
| Amgen INC. | $736.69 | 2019-2021 | |
| Lilly USA, LLC | $411.48 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $254.42 | 2019-2020 | |
| Ucb, INC. | $199.98 | 2019-2021 | |
| Janssen Biotech, INC. | $83.59 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.00 | 2019-2020 | |
| Celgene Corporation | $29.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $27.34 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $27.26 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $25.92 | 2019 | |
| Genentech USA, INC. | $14.36 | 2019 | |
| Medexus Pharma, INC. | $12.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randal White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.